Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Fujiwara

Showing results (1-10 of 406) with videos related to

Pageof 41
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 8, 2011
[Cellular immunotherapy with genetically engineered T-cell therapy for malignancies]Hiroshi Fujiwara
Molecular Human Reproduction|April 7, 2009
Do circulating blood cells contribute to maternal tissue remodeling and embryo-maternal cross-talk around the implantation period?Hiroshi Fujiwara
Pharmaceuticals (Basel, Switzerland)|December 18, 2014
Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptorsHiroshi Fujiwara
International Journal of Hematology|December 20, 2013
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptorsHiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Strategical consideration of the interaction between tumor microenvironment and tumor immunity]Hiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2009
Identification of hematological malignancy-associated antigens and clinical applicationsHiroshi Fujiwara
International Journal of Hematology|September 13, 2021
Efforts to maximize the potential of CAR-T therapy for cancer, from T-bodies to CAR-immune cellsHiroshi Fujiwara
Reproductive Medicine and Biology|April 18, 2018
Functional roles of cell surface peptidases in reproductive organsHiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Adoptive immunotherapy using gene-modified T cells to express target-specific receptors against hematological malignancy]Hiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Redirected T cell-based antileukemia adoptive immunotherapy using tumor antigen-specific TCR gene transfer]Hiroshi Fujiwara
Pageof 41

Showing results (1-10 of 406) with videos related to

Sort By:
Pageof 41
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 8, 2011
[Cellular immunotherapy with genetically engineered T-cell therapy for malignancies]Hiroshi Fujiwara
Molecular Human Reproduction|April 7, 2009
Do circulating blood cells contribute to maternal tissue remodeling and embryo-maternal cross-talk around the implantation period?Hiroshi Fujiwara
Pharmaceuticals (Basel, Switzerland)|December 18, 2014
Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptorsHiroshi Fujiwara
International Journal of Hematology|December 20, 2013
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptorsHiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Strategical consideration of the interaction between tumor microenvironment and tumor immunity]Hiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2009
Identification of hematological malignancy-associated antigens and clinical applicationsHiroshi Fujiwara
International Journal of Hematology|September 13, 2021
Efforts to maximize the potential of CAR-T therapy for cancer, from T-bodies to CAR-immune cellsHiroshi Fujiwara
Reproductive Medicine and Biology|April 18, 2018
Functional roles of cell surface peptidases in reproductive organsHiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 10, 2014
[Adoptive immunotherapy using gene-modified T cells to express target-specific receptors against hematological malignancy]Hiroshi Fujiwara
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Redirected T cell-based antileukemia adoptive immunotherapy using tumor antigen-specific TCR gene transfer]Hiroshi Fujiwara
Pageof 41